TSC2 and neoplasm with perivascular epithelioid cell differentiation: TSC2 mutations were found in 80% of TFE3 fusion-negative cases and concomitant p53 mutations were noted in 63% of TSC2-mutated cases, which confirmed the hypothesis that different molecular pathways could be involved in the pathogenesis of PEComas.